Bronstein, Gewirtz and Grossman, LLC announces an investigation of PTC Therapeutics, Inc. and urges investors to contact the company today!

NEW YORK CITY, NY / ACCESSWIRE / July 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. (“PTC” or “the Company”) (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist in the investigation by visiting the Company’s website: bgandg.com/PTCT.

Examination details

On June 28, 2024, PTC announced in a press release that the European Medicines Agency’s Committee for Medicinal Products for Human Use “has issued a negative opinion on the renewal of the conditional marketing authorization of Translarna™ (ataluren) for the treatment of nmDMD,” which “follows the return of the negative opinion previously issued by the European Commission (EC) for re-examination.” Following this news, PTC’s share price fell $4.08 per share, or 11.77%, closing at $30.58 per share on June 28, 2024.

What’s next?

If you know of any facts related to this investigation or any PTC securities you have purchased, you may assist this investigation by visiting the Company’s website: bgandg.com/PTCT. You may also contact Peretz Bronstein or his account manager Nathan Miller of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There are no costs for you

We represent investors in class action lawsuits on a contingency basis, meaning we ask the court to reimburse us for our expenses and attorney fees (usually a percentage of the total award) only if we win.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm representing investors in securities fraud class action lawsuits and shareholder actions involving derivatives trading. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Past results do not guarantee similar results.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | (email protected)

SOURCE: Bronstein, Gewirtz & Grossman, LLC